News Center
We closed our $1.45 Million seed round led by HealthX Ventures!
We closed our $1.45 Million seed round led by HealthX Ventures!
Remote Therapeutic Monitoring (RTM) is moving to general supervision in 2023!
CMS announced RTM will be under general supervision in 2023!
Accelerating Innovation: Helping Patients and Caregivers Follow Doctors' Orders on Prescription Drugs
Medsense Health has been featured in the Blue Cross and Blue Shield of Illinois, Montana, New Mexico, Oklahoma & Texas newsroom!
We were selected to participate In the Blue Cross Blue Shield of Illinois early-stage accelerator program!
Medsense Health was selected to participate In the Blue Cross Blue Shield of Illinois early-stage accelerator program!